Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sargent

Showing results (401-410 of 433) with videos related to

Pageof 44
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group StudyMegan M Garrity, Lawrence J Burgart, Michelle R Mahoney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumorsNoralane M Lindor, Lawrence J Burgart, Olga Leontovich, et al.
JAMA|April 5, 2012
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trialSteven R Alberts, Daniel J Sargent, Suresh Nair, et al.
NPJ Parkinson'S Disease|December 16, 2022
Identification and prediction of Parkinson's disease subtypes and progression using machine learning in two cohortsAnant Dadu, Vipul Satone, Rachneet Kaur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trialsDaniel J Sargent, Harry S Wieand, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized TrialsQian Shi, Christopher R Flowers, Wolfgang Hiddemann, et al.
The Lancet. Oncology|October 17, 2016
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) databaseJan Franko, Qian Shi, Jeffrey P Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012Herbert H Pang, Xiaofei Wang, Thomas E Stinchcombe, et al.
The New England Journal of Medicine|March 29, 2018
Duration of Adjuvant Chemotherapy for Stage III Colon CancerAxel Grothey, Alberto F Sobrero, Anthony F Shields, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2018
Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD databaseMohamed E Salem, Jun Yin, Benjamin A Weinberg, et al.
Pageof 44

Showing results (401-410 of 433) with videos related to

Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group StudyMegan M Garrity, Lawrence J Burgart, Michelle R Mahoney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumorsNoralane M Lindor, Lawrence J Burgart, Olga Leontovich, et al.
JAMA|April 5, 2012
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trialSteven R Alberts, Daniel J Sargent, Suresh Nair, et al.
NPJ Parkinson'S Disease|December 16, 2022
Identification and prediction of Parkinson's disease subtypes and progression using machine learning in two cohortsAnant Dadu, Vipul Satone, Rachneet Kaur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trialsDaniel J Sargent, Harry S Wieand, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized TrialsQian Shi, Christopher R Flowers, Wolfgang Hiddemann, et al.
The Lancet. Oncology|October 17, 2016
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) databaseJan Franko, Qian Shi, Jeffrey P Meyers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012Herbert H Pang, Xiaofei Wang, Thomas E Stinchcombe, et al.
The New England Journal of Medicine|March 29, 2018
Duration of Adjuvant Chemotherapy for Stage III Colon CancerAxel Grothey, Alberto F Sobrero, Anthony F Shields, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2018
Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD databaseMohamed E Salem, Jun Yin, Benjamin A Weinberg, et al.
Pageof 44